You are here

Resource Center

AdvaMed Comments on Re: Input for the Food and Drug Administration’s Consideration in Developing Draft Guidance To Implement Section 702 of the of the Food and Drug Administration Reauthorization Act

Comments

application/pdf - 136 kB
Date:
03/09/2018
Issues: